Gerber Kawasaki Wealth & Investment Management Gilead Sciences, Inc. Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.16 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $397,000 - $450,603	-6,119 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $414,195 - $446,870	6,119 New	6,119 $427,000
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $1.94 Million - $2.44 Million	-31,296 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $244,581 - $284,004	-3,381 Reduced 9.75%	31,296 $2.41 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $2.17 Million - $2.78 Million	34,677 New	34,677 $2.59 Million
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $196,210 - $256,039	-3,241 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $86,747 - $96,045	-1,217 Reduced 27.3%	3,241 $252,000
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $4,282 - $4,994	66 Added 1.5%	4,458 $317,000
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $101,029 - $123,165	-1,387 Reduced 24.0%	4,392 $331,000
Q4 2017 Feb 06, 2018	SELL	$71.15 - $83.52 $133,904 - $157,184	-1,882 Reduced 24.57%	5,779 $414,000
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $307,837 - $364,871	-4,269 Reduced 35.78%	7,661 $628,000
Q2 2017 Aug 09, 2017	BUY	N/A	11,930	11,930 $826,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account